Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developing a Hetero-Trinuclear Erbium(III)–Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor
Minghui Zhu, Xueyu Man, Yang Tongfu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15424-15436
Closed Access | Times Cited: 11

Showing 11 citing articles:

Developing a Copper(II) Isopropyl 2-Pyridyl Ketone Thiosemicarbazone Compound Based on the IB Subdomain of Human Serum Albumin–Indomethacin Complex: Inhibiting Tumor Growth by Remodeling the Tumor Microenvironment
Xueyu Man, Shanhe Li, Gang Xu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 7, pp. 5744-5757
Closed Access | Times Cited: 16
Copper-Based Nanomaterials for Image-Guided Cancer Therapy
Haonan Xu, Zhili Guo, Mingjie Li, et al.
BIO Integration (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 5
Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate
Yunhan Jiang, Xiaoqiu Xu, Dongmei Fan, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 16, pp. 13959-13974
Closed Access | Times Cited: 4
Developing a Palladium(II) Agent to Overcome Multidrug Resistance and Metastasis of Liver Tumor by Targeted Multiacting on Tumor Cell, Inactivating Cancer-Associated Fibroblast and Activating Immune Response
Ming Jiang, Wenjuan Li, Jinzhe Liang, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16296-16310
Closed Access | Times Cited: 4
Developing a Rhodium(III) Complex to Reprogram the Tumor Immune and Metabolic Microenvironments: Overcoming Multidrug Resistance and Metastasis in Non-Small Cell Lung Cancer
Wenjuan Li, Shanhe Li, Minghui Zhu, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 19, pp. 17243-17258
Closed Access | Times Cited: 4
Mechanisms of Copper-Induced Autophagy and Links with Human Diseases
Yuanyuan Fu, Shuyan Zeng, Zhenlin Wang, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 99-99
Open Access
Vertasile ferritin nanocages: Applications in detection and bioimaging
Y.B. Chen, Xu Chen, Mingyang Sun, et al.
Biosensors and Bioelectronics (2024) Vol. 262, pp. 116567-116567
Closed Access | Times Cited: 3
In vitro and In vivo anticancer activities of Bi(III) 2-thiazolecarboxaldehyde thiosemicarbazone complex
Xiaoying Jia, Jinhui Pang, Yong Kyu Chu, et al.
Journal of Molecular Structure (2024) Vol. 1318, pp. 139389-139389
Closed Access | Times Cited: 3
Recent advances in the development of metallodrugs for cancer chemoimmunotherapy
Fangmian Wei, Jinzhe Liang, Xing‐Can Shen, et al.
Coordination Chemistry Reviews (2024) Vol. 526, pp. 216319-216319
Closed Access | Times Cited: 3
Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer
Gang Xu, Qiongyue Liang, Lijuan Gao, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 2
Lanthanides and their complexes/nanoparticles: A review of cancer diagnosis, therapeutics, toxicity considerations, and clinical trials
Tatenda Madanhire, Louis‐Charl C. Coetzee, Adedapo S. Adeyinka, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106561-106561
Closed Access | Times Cited: 1
Page 1

Scroll to top